Pathophysiology of parkinsonian motor abnormalities.
Wichmann
T
T
Department of Neurology, Emory University, Atlanta, Georgia 30021.
DeLong
M R
MR
D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; D000818:Animals; D001479:Basal Ganglia / Q000187:drug effects / Q000503:physiopathology; D001931:Brain Mapping; D002540:Cerebral Cortex / Q000187:drug effects / Q000503:physiopathology; D002522:Chlorocebus aethiops; D009048:Motor Skills / Q000187:drug effects / Q000502:physiology*; D009069:Movement Disorders / Q000503:physiopathology*; D009127:Muscle Rigidity / Q000139:chemically induced / Q000503:physiopathology*; D009434:Neural Pathways / Q000187:drug effects / Q000503:physiopathology; D009474:Neurons / Q000187:drug effects / Q000502:physiology; D010300:Parkinson Disease / Q000503:physiopathology*; D010302:Parkinson Disease, Secondary / Q000139:chemically induced / Q000503:physiopathology*; D013787:Thalamic Nuclei / Q000187:drug effects / Q000503:physiopathology; D014202:Tremor / Q000139:chemically induced / Q000503:physiopathology*
D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine